Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
Study identifier:NIS-RSI-SYM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
400
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2008
Primary Completion Date: -
Study Completion Date: 01 Apr 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 patients with maintenance only treatment with Symbicort Turbuhaler for at least 1 month | - |
| 2 patients with SMART treatment with Symbicort Turbuhaler for at least 1 month | - |
Contacts
Investigators
Principal Investigator
Igor Koren
Radix - medicinske storitve, Igor Koren s.p.
